Chinese AI vendor Keya Medical recently announced that its AI-powered FFR-CT solution, DEEPVESSEL FFR is now available for clinical use in the US.

The availability follows the US-FDA clearance of the solution, and a significant clinical validation study, which was conducted at multiple international sites and on a range of patient populations.

Keya Medical is not a typical Chinese AI developer. Not only was it one of the first of the country’s vendors to receive US-FDA clearance,